Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Advocates often stress the possibility for substantial therapeutic gains, principally in ailments where conventional therapies have proven ineffective. However, crucially important to assess the substantial financial burden associated with CPI stem ce